First Tracks Biotherapeutics, Inc.
TRAX
$44.04
$0.010.02%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 40.25% | 92.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -23.88% | 2.99% | |||
| Operating Income | 23.88% | -2.99% | |||
| Income Before Tax | 21.37% | -6.97% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 21.37% | -6.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 21.37% | -6.97% | |||
| EBIT | 23.88% | -2.99% | |||
| EBITDA | 23.87% | -3.04% | |||
| EPS Basic | 35.28% | -- | |||
| Normalized Basic EPS | 35.28% | -- | |||
| EPS Diluted | 35.28% | -- | |||
| Normalized Diluted EPS | 35.28% | -- | |||
| Average Basic Shares Outstanding | 21.50% | -- | |||
| Average Diluted Shares Outstanding | 21.50% | -- | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||